94 results
Page 4 of 5
8-K
EX-99.1
rwjz5df1
11 Mar 20
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.1
rzx4p25 m12
10 Feb 20
Regulation FD Disclosure
7:05am
8-K
EX-99.1
mqp446or1ll c40l
6 Feb 20
Aquestive Therapeutics Announces FDA Confirmed 505(b)(2) Pathway for Pivotal Pharmacokinetic (PK) Clinical Trials Planned To Be Initiated Before Year End 2020
7:49am
8-K
EX-99.1
0kgnws7lohbdownok13l
13 Jan 20
Aquestive Therapeutics Receives FDA Response to Citizen’s Petition
6:01am
8-K
EX-99.1
at67q
10 Jan 20
Results of Operations and Financial Condition
6:35am
8-K
EX-99.1
u9xanxq3j1w
16 Dec 19
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
5:26pm
8-K
EX-99.2
fdfwrh9q
16 Dec 19
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
5:26pm
8-K
EX-99.1
0cwjdvrgim6me8 nfo
2 Dec 19
Regulation FD Disclosure
7:35am
8-K
EX-99.1
o6lwn
25 Nov 19
Aquestive Therapeutics Receives FDA Approval for Exservan™ (riluzole) Oral Film
8:03am
8-K
EX-99.1
8caboap
13 Nov 19
Aquestive Therapeutics Licenses Riluzole Oral Film to Zambon for Development and Commercialization in the EU for Patients with ALS
8:48am
8-K
EX-99.1
zxc9m4ao3l8c84k
5 Nov 19
Aquestive Therapeutics Reports Third Quarter 2019 Financial Results and Raises 2019 Guidance
5:01pm
8-K
EX-99.1
f8x9om4
16 Oct 19
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
p86yn5p0kg
30 Sep 19
Aquestive Therapeutics Announces Successful Completion of Phase 1 Trial for AQST-108
7:00am
8-K
EX-99.2
kmsqq195 2i8
6 Aug 19
Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
5:07pm
8-K
EX-99.1
0312aagk5
6 Aug 19
Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
5:07pm
8-K
EX-99.1
q4va9k4 q4
16 Jul 19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
12:00am
8-K
EX-99.1
hvefdm8
8 May 19
Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights
7:02am
DEF 14A
l549k
26 Apr 19
Definitive proxy
11:18am